Evidence map›Paper›PMID 30796268›Full record

ArticleScientific reports2019

Increased susceptibility of airway epithelial cells from ataxia-telangiectasia to S. pneumoniae infection due to oxidative damage and impaired innate immunity.

Abrey J Yeo, Anna Henningham, Emmanuelle Fantino, Sally Galbraith, Lutz Krause, Claire E Wainwright, Peter D Sly, Martin F Lavin

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04513002 (A Phase 2A/2B Placebo-controlled Randomised Clinical Trial to Test the Ability of Triheptanoin to Protect Primary Airway Epithelial Cells Obtained From Participants With Ataxia-telangiectasia Against Death Induced by Glucose Deprivation), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04513002 phase2completednot on this mapstarted 2022, after this paper: background citation

A Phase 2A/2B Placebo-controlled Randomised Clinical Trial to Test the Ability of Triheptanoin to Protect Primary Airway Epithelial Cells Obtained From Participants With Ataxia-telangiectasia Against Death Induced by Glucose Deprivation

TypeinterventionalSponsorThe University of QueenslandRan2022 to 2023Enrolled30ConditionsAtaxia TelangiectasiaArmsTriheptanoin
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. [An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Abrey J YeoNeuroscience & Infectious Disease Group, The University of Queensland Centre for Clinical Research, Herston, Queensland, Australia.
Anna HenninghamChildren's Lung, Environment and Asthma Research (CLEAR) Group, Child Health Research Centre, The University of Queensland, South Brisbane, Queensland, Australia.
Emmanuelle FantinoChildren's Lung, Environment and Asthma Research (CLEAR) Group, Child Health Research Centre, The University of Queensland, South Brisbane, Queensland, Australia.
Sally GalbraithChildren's Lung, Environment and Asthma Research (CLEAR) Group, Child Health Research Centre, The University of Queensland, South Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0001-9102-3846
Lutz KrauseThe University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, Australia.ORCID http://orcid.org/0000-0003-3806-0845
Claire E WainwrightChildren's Lung, Environment and Asthma Research (CLEAR) Group, Child Health Research Centre, The University of Queensland, South Brisbane, Queensland, Australia.
Peter D SlyChildren's Lung, Environment and Asthma Research (CLEAR) Group, Child Health Research Centre, The University of Queensland, South Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0001-6305-2201
Martin F LavinNeuroscience & Infectious Disease Group, The University of Queensland Centre for Clinical Research, Herston, Queensland, Australia. m.lavin@uq.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory disease is a major cause of morbidity and mortality in patients with ataxia-telangiectasia (A-T) who are prone to recurrent sinopulmonary infections, bronchiectasis, pulmonary fibrosis, and pulmonary failure. Upper airway infections are common in patients and S. pneumoniae is associated with these infections. We demonstrate here that the upper airway microbiome in patients with A-T is different from that to healthy controls, with S. pneumoniae detected largely in patients only. Patient-specific airway epithelial cells and differentiated air-liquid interface cultures derived from these were hypersensitive to infection which was at least in part due to oxidative damage since it was partially reversed by catalase. We also observed increased levels of the pro-inflammatory cytokines IL-8 and TNF-α (inflammasome-independent) and a decreased level of the inflammasome-dependent cytokine IL-β in patient cells. Further investigation revealed that the ASC-Caspase 1 signalling pathway was defective in A-T airway epithelial cells. These data suggest that the heightened susceptibility of these cells to S. pneumoniae infection is due to both increased oxidative damage and a defect in inflammasome activation, and has implications for lung disease in these patients.

Indexed as

Immunity, InnateOxidative StressAdolescentAtaxia TelangiectasiaAtaxia Telangiectasia Mutated ProteinsCase-Control StudiesCell DifferentiationCells, CulturedChildChild, PreschoolEpithelial CellsFemaleHumansInflammasomesInflammationLungAtaxia Telangiectasia Mutated ProteinsInflammasomes

Identifiers

PMID30796268
PMCPMC6385340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.